GM0N Stock Overview
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Globus Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$47.80 |
| 52 Week High | US$56.00 |
| 52 Week Low | US$40.80 |
| Beta | 1.1 |
| 1 Month Change | 1.70% |
| 3 Month Change | -3.24% |
| 1 Year Change | -8.08% |
| 3 Year Change | -19.19% |
| 5 Year Change | 22.05% |
| Change since IPO | 316.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| GM0N | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -0.4% | 2.1% | 0.5% |
| 1Y | -8.1% | -8.4% | 1.3% |
Return vs Industry: GM0N matched the German Medical Equipment industry which returned -7.7% over the past year.
Return vs Market: GM0N underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| GM0N volatility | |
|---|---|
| GM0N Average Weekly Movement | 3.3% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: GM0N has not had significant price volatility in the past 3 months.
Volatility Over Time: GM0N's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 5,000 | Dan Scavilla | www.globusmedical.com |
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants.
Globus Medical, Inc. Fundamentals Summary
| GM0N fundamental statistics | |
|---|---|
| Market cap | €6.49b |
| Earnings (TTM) | €114.54m |
| Revenue (TTM) | €1.46b |
55.5x
P/E Ratio4.3x
P/S RatioIs GM0N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GM0N income statement (TTM) | |
|---|---|
| Revenue | US$1.57b |
| Cost of Revenue | US$476.52m |
| Gross Profit | US$1.09b |
| Other Expenses | US$969.09m |
| Earnings | US$122.87m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | 0.91 |
| Gross Margin | 69.62% |
| Net Profit Margin | 7.83% |
| Debt/Equity Ratio | 10.4% |
How did GM0N perform over the long term?
See historical performance and comparison